Living Cell Technologies (ASX:LCT) Share Price and News - StockTrack

Market Cap (30-Oct) TBC	Close (30-Jun) $0.015 0 (0%)	Volume (30-Jun) 1,798,203	Shortsold (17-Dec) 60,100 (0.01%) (538th)
52w High $0.000	52w Low $0.000	P/E -	EPS -

	Subject
	LCT LCT Ann: Appendix 4G and Corporate Governance Statement
	1 (current) 2 3
	LCT LCT Ann: Annual Report to Shareholders
	LCT LCT Ann: NEW 2022 Annual General Meeting Date
	LCT LCT Ann: 2022 Annual General Meeting Date
	LCT LCT Ann: New milestone for LCT's AI development
	LCT LCT Ann: Becoming a substantial holder
	LCT LCT Ann: Receipt of Section 249D Notice
	LCT LCT Ann: Change of Director's Interest Notice - R Willcocks
	LCT LCT Ann: Notification regarding unquoted securities - LCT
	LCT LCT Ann: Notification of cessation of securities - LCT
	LCT LCT Ann: Preliminary Final Report and 2022 Financial Statements
	LCT LCT Ann: NTCELL Update - Choroid plexus tissue shipped to Sydney
	LCT LCT Ann: Quarterly Activity Report and Appendix 4C
	LCT LCT Ann: Change of Director's Interest Notice - B Tuch and A Kelly
	LCT LCT Ann: Ceasing to be a substantial holder
	LCT LCT Ann: NTCELL -Investor Presentation
	LCT LCT Ann: LCT Presenting at Gold Coast Investment Showcase
	LCT LCT Ann: Change of Director's Interest Notice - C Sue
	LCT LCT Ann: Change of Director's Interest Notice - R Willcocks
	LCT LCT Ann: Cleansing Notice
	LCT LCT Ann: Application for quotation of securities - LCT
	LCT LCT Ann: Proposed issue of securities - LCT
	LCT LCT Ann: LCT Completes Strategic A$1.285M Placement
	LCT LCT Ann: Trading Halt
	LCT LCT Ann: Artificial Intelligence to advance NTCELL Production
	LCT LCT Ann: Application for quotation of securities - LCT
	LCT LCT Ann: LCT Newsletter - May 2022
	LCT LCT Ann: Quarterly Activity Report and Appendix 4C
	LCT LCT Ann: Cleansing Notice
	LCT LCT Ann: Proposed issue of securities - LCT
	LCT LCT Ann: Results of General Meeting
	LCT LCT Ann: Investor Presentation
	LCT LCT Ann: Chairman's Address to the General Meeting
	LCT LCT Ann: LCT signs Research Agreement with UTS
	LCT LCT Ann: Notice of General Meeting/ Proxy Form
	LCT LCT Ann: Funding Update-LCT Advancing NTCELL with Investor Backing
	LCT LCT Ann: Investor Presentation
	LCT LCT Ann: Investor Webinar
	LCT LCT Ann: Change of Address
	LCT LCT Ann: LCT Interim CEO Term Extended as NTCELL Advances
	LCT LCT Ann: Half Yearly Report and Accounts
	LCT LCT Ann: Quarterly Activity Report and Appendix 4C
	LCT LCT Ann: LCT Signs Service Agreement with NZeno
	LCT LCT Ann: Update - Application for quotation of securities - LCT
	LCT LCT Ann: Application for quotation of securities - LCT
	LCT LCT Ann: Results of Rights Issue
	LCT LCT Ann: Update - Appendix 2A- Issue of shares and Options
	LCT LCT Ann: Notification of cessation of securities - LCT
	LCT LCT Ann: Application for quotation of securities - LCT
	LCT LCT Ann: LCT Appoints COO to Establish NTCELL Trial

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
30-Oct	$0.01	1,712,816	0.00 (0.00%)
23-Oct	$0.01	1,715,045	0.00 (7.69%)
20-Oct	$0.01	1,426,065	0.00 (0.00%)
19-Oct	$0.01	7,473	0.00 (0.00%)
18-Oct	$0.01	625,000	+0.00 (8.33%)
17-Oct	$0.01	1,292,941	0.00 (7.69%)
16-Oct	$0.01	329,192	0.00 (7.14%)
13-Oct	$0.01	220,186	+0.00 (16.67%)
12-Oct	$0.01	1,662,073	0.00 (7.69%)
11-Oct	$0.01	1,252,294	0.00 (7.14%)
10-Oct	$0.01	3,246,085	+0.00 (7.69%)
09-Oct	$0.01	1,378,040	0.00 (7.14%)
06-Oct	$0.01	500,334	0.00 (0.00%)
05-Oct	$0.01	1,349,330	0.00 (6.67%)
04-Oct	$0.02	346,772	0.00 (0.00%)
3 up, 7 down, and 5 flat days

High $0.02	Low $0.02	Trades 21	Turnover $27,023	Volume 1,798,203
30 June 2023 at 2:47pm

High $0.02	Low $0.02	Trades 21	Turnover $27,023	Volume 1,798,203
30 June 2023 at 2:47pm

Living Cell Technologies Health Care

$0.015 (0%)

$0.015 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices